Recent reports have shown that TGF-β1 promoted the development of HCC by inducing hepatocyte apoptosis and compensatory proliferation during the early phases of tumorigenesis [9, 28, 29]; therefore, TGF-β1 signaling could be a therapeutic intervention in HCC [30]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.